Preferred Label : vibegron;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3638482/fr/obgemsa-vibegron-hyperactivite-vesicale-hav-chez-l-adulte
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
vibegron
Product containing precisely vibegron 75 milligram/1 each conventional release oral tablet (clinical drug)
evaluation of the transparency committee
urinary bladder, overactive
adult
vibegron

---
https://www.ema.europa.eu/en/medicines/human/EPAR/obgemsa
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
vibegron
vibegron
drug approval
europe
vibegron
urinary bladder, overactive
adult
administration, oral
product surveillance, postmarketing
pregnancy
breast feeding
adrenergic beta-3 receptor agonists
adrenergic beta-3 receptor agonists
drug evaluation, preclinical

---
Nous contacter.
06/09/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.